CENTENE CORPORATION (CNC) Current Ratio
- Current ratio · latest quarter: Value 1.15×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.15× | Current assets / current liabilities. $46.69B ÷ $40.76B ≈ 1.15× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 46.69B USD | Assets, Current |
| Current obligations | 40.76B USD | Liabilities, Current |
| Cash and equivalents | 24.15B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | (m) | |
| Borrowing debt due within one year | 75.00M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $46.69B | $40.76B | $24.15B | (m) | (m) | (m) | (m) | $75.00M | 1.15× |
| 2026-03-31 | $44.99B | $40.05B | $21.26B | (m) | (m) | (m) | (m) | $63.00M | 1.12× |
| 2025-12-31 | $40.37B | $36.72B | $17.89B | (m) | (m) | (m) | (m) | $50.00M | 1.10× |
| 2025-09-30 | $44.06B | $40.63B | $17.06B | (m) | (m) | (m) | (m) | $38.00M | 1.08× |
| 2025-06-30 | $40.39B | $36.79B | $14.51B | (m) | (m) | (m) | (m) | $25.00M | 1.10× |
| 2025-03-31 | $41.29B | $37.14B | $14.81B | (m) | (m) | (m) | (m) | $12.00M | 1.11× |
| 2024-12-31 | $38.00B | $34.26B | $14.06B | (m) | (m) | (m) | (m) | $110.00M | 1.11× |
| 2024-09-30 | $37.41B | $34.06B | $14.58B | (m) | (m) | (m) | (m) | $111.00M | 1.10× |
| 2024-06-30 | $38.41B | $32.73B | $17.61B | (m) | (m) | (m) | (m) | $112.00M | 1.17× |
| 2024-03-31 | $38.45B | $32.78B | $17.59B | (m) | (m) | (m) | (m) | $113.00M | 1.17× |
| 2023-12-31 | $40.76B | $36.72B | $17.19B | (m) | (m) | (m) | (m) | $119.00M | 1.11× |
| 2023-09-30 | $41.41B | $36.85B | $18.19B | (m) | (m) | (m) | (m) | $113.00M | 1.12× |
| 2023-06-30 | $34.87B | $31.31B | $17.17B | (m) | (m) | (m) | (m) | $110.00M | 1.11× |
| 2023-03-31 | $35.01B | $32.86B | $15.85B | (m) | (m) | (m) | (m) | $97.00M | 1.07× |
| 2022-12-31 | $30.13B | $28.46B | $12.07B | (m) | (m) | (m) | (m) | $82.00M | 1.06× |
| 2022-09-30 | $33.27B | $31.33B | $14.99B | (m) | (m) | (m) | (m) | $249.00M | 1.06× |
| 2022-06-30 | $32.41B | $29.09B | $13.44B | (m) | (m) | (m) | (m) | $300.00M | 1.11× |
| 2022-03-31 | $31.11B | $29.68B | $11.24B | (m) | (m) | (m) | (m) | $292.00M | 1.05× |
| 2021-12-31 | $28.50B | $25.77B | $13.12B | (m) | (m) | (m) | (m) | $267.00M | 1.11× |
| 2021-09-30 | $28.06B | $25.04B | $13.42B | (m) | (m) | (m) | (m) | $245.00M | 1.12× |
| 2021-06-30 | $25.46B | $23.64B | $11.02B | (m) | (m) | (m) | (m) | $253.00M | 1.08× |
| 2021-03-31 | $24.44B | $22.28B | $9.63B | (m) | (m) | (m) | (m) | $62.00M | 1.10× |
| 2020-12-31 | $23.39B | $21.59B | $10.80B | (m) | (m) | (m) | (m) | $97.00M | 1.08× |
| 2020-09-30 | $27.27B | $21.80B | $12.20B | (m) | (m) | (m) | (m) | $89.00M | 1.25× |
| 2020-06-30 | $26.82B | $21.92B | $12.80B | (m) | (m) | (m) | (m) | $106.00M | 1.22× |
| 2020-03-31 | $24.70B | $21.65B | $9.31B | (m) | (m) | (m) | (m) | $129.00M | 1.14× |
| 2019-12-31 | $20.32B | $12.93B | $12.12B | (m) | (m) | (m) | (m) | $88.00M | 1.57× |
| 2019-09-30 | $13.46B | $13.28B | $6.21B | (m) | (m) | (m) | (m) | $66.00M | 1.01× |
| 2019-06-30 | $13.60B | $12.65B | $6.88B | (m) | (m) | (m) | (m) | $87.00M | 1.07× |
| 2019-03-31 | $13.62B | $13.14B | $6.34B | (m) | (m) | (m) | (m) | $40.00M | 1.04× |
| 2018-12-31 | $12.00B | $11.97B | $5.34B | (m) | (m) | (m) | (m) | $38.00M | 1.00× |
| 2018-09-30 | $13.09B | $12.74B | $6.85B | (m) | (m) | (m) | (m) | $4.00M | 1.03× |
| 2018-06-30 | $12.38B | $9.86B | $6.71B | (m) | (m) | (m) | (m) | $4.00M | 1.26× |
| 2018-03-31 | $10.98B | $10.89B | $5.67B | (m) | (m) | (m) | (m) | $4.00M | 1.01× |
| 2017-12-31 | $8.70B | $9.33B | $4.07B | (m) | (m) | (m) | (m) | $4.00M | 0.93× |
| 2017-09-30 | $9.66B | $9.71B | $4.28B | (m) | (m) | (m) | (m) | $4.00M | 0.99× |
| 2017-06-30 | $9.65B | $8.97B | $4.42B | (m) | (m) | (m) | (m) | $4.00M | 1.08× |
| 2017-03-31 | $9.41B | $9.20B | $4.84B | (m) | (m) | (m) | (m) | $4.00M | 1.02× |
| 2016-12-31 | $8.37B | $8.62B | $3.93B | (m) | (m) | (m) | (m) | $4.00M | 0.97× |
| 2016-09-30 | $7.75B | $9.02B | $2.98B | (m) | (m) | (m) | (m) | $845.00M | 0.86× |
| 2016-06-30 | $7.85B | $8.81B | $2.71B | (m) | (m) | (m) | (m) | $845.00M | 0.89× |
| 2016-03-31 | $7.55B | $7.87B | $3.44B | (m) | (m) | (m) | (m) | $4.00M | 0.96× |
| 2015-12-31 | $3.60B | $3.63B | $1.76B | (m) | (m) | (m) | (m) | $5.00M | 0.99× |
| 2015-09-30 | $3.60B | $3.56B | $1.67B | (m) | (m) | (m) | (m) | $5.00M | 1.01× |
| 2015-06-30 | $3.84B | $3.46B | $1.97B | (m) | (m) | (m) | (m) | $5.00M | 1.11× |
| 2015-03-31 | $3.59B | $3.34B | $1.67B | (m) | (m) | (m) | (m) | $5.00M | 1.07× |
| 2014-12-31 | $2.95B | $2.90B | $1.61B | (m) | (m) | (m) | (m) | $5.00M | 1.02× |
| 2014-09-30 | $2.77B | $2.63B | $1.52B | (m) | (m) | (m) | (m) | $5.13M | 1.05× |
| 2014-06-30 | $2.32B | $2.12B | $1.20B | (m) | (m) | (m) | (m) | $6.13M | 1.10× |
| 2014-03-31 | $2.28B | $2.02B | $1.22B | (m) | (m) | (m) | (m) | $6.11M | 1.13× |
| 2013-12-31 | $1.80B | $1.56B | $974.00M | (m) | (m) | (m) | (m) | $3.00M | 1.15× |
| 2013-09-30 | $1.37B | $1.39B | $741.28M | (m) | (m) | (m) | (m) | $3.05M | 0.99× |
| 2013-06-30 | $1.34B | $1.32B | $688.71M | (m) | (m) | (m) | (m) | $3.03M | 1.02× |
| 2013-03-31 | $1.38B | $1.31B | $730.79M | (m) | (m) | (m) | (m) | $3.42M | 1.05× |
| 2012-12-31 | $1.41B | $1.23B | $745.93M | (m) | (m) | (m) | (m) | $3.37M | 1.14× |
| 2012-09-30 | $1.38B | $1.28B | $796.62M | (m) | (m) | (m) | (m) | $3.34M | 1.08× |
| 2012-06-30 | $1.07B | $1.03B | $421.89M | (m) | (m) | (m) | (m) | $3.30M | 1.04× |
| 2012-03-31 | $920.38M | $888.32M | $433.00M | (m) | (m) | (m) | (m) | $3.23M | 1.04× |
| 2011-12-31 | $940.01M | $837.61M | $573.70M | (m) | (m) | (m) | (m) | $3.23M | 1.12× |
| 2011-09-30 | $766.38M | $730.38M | $451.66M | (m) | (m) | (m) | (m) | $3.20M | 1.05× |
| 2011-06-30 | $774.54M | $749.77M | $474.45M | (m) | (m) | (m) | (m) | $3.17M | 1.03× |
| 2011-03-31 | $743.83M | $817.05M | $492.05M | (m) | (m) | (m) | (m) | $3.04M | 0.91× |
| 2010-12-31 | $656.82M | $765.25M | (m) | (m) | (m) | (m) | (m) | $2.82M | 0.86× |
| 2010-09-30 | $675.99M | $661.09M | $397.67M | (m) | (m) | (m) | (m) | $663.00K | 1.02× |
| 2010-06-30 | $545.84M | $636.82M | $265.60M | (m) | (m) | (m) | (m) | $771.00K | 0.86× |
| 2009-12-31 | $616.13M | $715.91M | $403.75M | (m) | (m) | (m) | (m) | $646.00K | 0.86× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |